In 2016, Adebayo Alonge founded RxAll, initially developing an AI-powered spectrometer to combat counterfeit medications. Despite early struggles, a pivot during COVID-19 turned RxAll into a comprehensive pharmacy workflow platform, enhancing success and profitability. By addressing pharmacies' operational needs, adoption surged from 5% to 92%, solidifying their market presence.